Welcome! The Huntington Study Group (HSG) is a non-profit group of clinical investigators from medical centers in the United States, Canada, Europe and Australia, experienced in the care of Huntington patients and dedicated to clinical research of Huntington disease.

The primary focus of the HSG is to conduct clinical research trials, including both treatment (interventional) and observational studies. Please see Clinical Trials in Progress for the current HSG trials.

 
ENROLLING STUDIES

August 2008 - The treatment trial that is currently enrolling is 2CARE.
August 2008 - The observational studies that are currently enrolling are COHORT and PREDICT-HD.
Please see Clinical Trials in Progress for a list of all ongoing HSG trials.

 

UPCOMING STUDIES

August 2008 - CREST-E, HART and PREQUEL will soon be enrolling. Please check back for updates on these and other potential future trials.

 

HUNTINGTON DISEASE CLINICAL RESEARCH SYMPOSIUM

The HSG is pleased to announce the Second Annual Huntington Disease Clinical Research Symposium which will be taking place Saturday, November 15, 2008, in St. Pete Beach, Florida. Registration is required and is now available online. The Keynote Speakers are Russell Katz, U.S. Food and Drug Administration and Charles Sabine, NBC News Correspondent and Jeremy Gruber, Legal Director of the National Workrights Institute. There will be both platform and poster presentations. Late-breaking abstracts are currently being accepted. For more information, please see the Second Annual Huntington Disease Clinical Research Symposium.